메뉴 건너뛰기




Volumn 80, Issue 3, 2002, Pages 277-281

Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy

Author keywords

blockers; Centrally acting adrenergic agonist; Exercise; Glaucoma; Premature contractions

Indexed keywords

BRIMONIDINE; HYPOTEARS; PLACEBO; TIMOLOL MALEATE;

EID: 0036083701     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2002.800309.x     Document Type: Article
Times cited : (22)

References (17)
  • 2
    • 0003866728 scopus 로고    scopus 로고
    • The Merck Manual of Diagnosis and Therapy
    • Merck Res Laboratories: Merck & Co., Inc., Whitehouse, NJ, USA
    • (1999) , pp. 1670-1679
    • Beers, M.H.1    Berkow, R.2
  • 3
    • 0005913231 scopus 로고
    • Essentials of Statistics New
    • York: McGraw-Hill Co. 117-122
    • (1978) , pp. 205-215
    • Book, S.1
  • 4
    • 0015184317 scopus 로고
    • Exercise testing of patients with coronary heart disease. Principles and normal standards for evaluation
    • (1971) Ann. Clin. Res , vol.3 , pp. 323-332
    • Bruce, R.A.1
  • 10
    • 0032901575 scopus 로고    scopus 로고
    • Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients
    • and the Brimonidine Study Group
    • (1999) Am. J. Ophthalmol , vol.127 , pp. 20-26
    • Katz, L.J.1
  • 13
    • 0029731764 scopus 로고    scopus 로고
    • Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension
    • (1996) Surv. Ophthalmol , vol.41
    • Schuman, J.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.